You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transverse myelitis, optic neuritis, neuromyelitis optica

Showing 1 - 25 of 1,388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rare Neuroimmunologic Disorders

Recruiting
  • Neuromyelitis Optica
  • +3 more
    • Dallas, Texas
      The University of Texas Southwestern Medical Center
    May 9, 2022

    Biobank For MS And Other Demyelinating Diseases

    Active, not recruiting
    • Multiple Sclerosis
    • +4 more
      • Phoenix, Arizona
      • +9 more
      Jul 19, 2021

      Neuropsychology and Imaging in CNS Demyelinating Syndromes.

      Active, not recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • +3 more
        • Dallas, Texas
          University Texas Southwestern
        Dec 14, 2022

        Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis Trial in Switzerland

        Recruiting
        • Optic Neuritis
        • +16 more
          • Aarau, Aargau, Switzerland
          • +11 more
          Aug 18, 2021

          Maintenance Plasma Exchange for Neuromyelitis Optica

          Completed
          • Neuromyelitis Optica
          • +2 more
          • Plasma exchange (PLEX)
          • Scottsdale, Arizona
          • +1 more
          Dec 7, 2021

          Optic Neuritis, Neuromyelitis Optica, Multiple Sclerosis Trial in Fort-de-France (Neuro-ophtalmology examination)

          Recruiting
          • Optic Neuritis
          • +2 more
          • Neuro-ophtalmology examination
          • Fort-de-France, France
            CHU of Martinique
          Feb 22, 2022

          Acute Optic Neuritis Network:International Study That

          Recruiting
          • Demyelinating Diseases
          • +4 more
          • non-interventional study
          • Aurora, Colorado
          • +25 more
          Oct 31, 2022

          Diagnosis of ON With or Without MS or NMOSD

          Enrolling by invitation
          • Multiple Sclerosis
          • +4 more
          • Reflex (Brightlamp Inc., Purdue University)
          • Lexington, Kentucky
            University of Kentucky
          Apr 27, 2021

          Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS Trial in Buffalo (Mitoxantrone)

          Completed
          • Neuromyelitis Optica
          • +3 more
          • Buffalo, New York
            Baird Multiple Sclerosis Center
          Dec 23, 2020

          Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Baltimore (Ublituximab)

          Completed
          Has Results
          • Neuromyelitis Optica
          • Neuromyelitis Optica Spectrum Disorder
          • Baltimore, Maryland
            Johns Hopkins University School of Medicine
          Jun 5, 2019

          Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica Spectrum Related Disorders Trial in Bron

          Completed
          • Neuromyelitis Optica Spectrum Disorders
          • Neuromyelitis Optica Spectrum Related Disorders
            • Bron, France
              Hospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer
            Mar 29, 2022

            Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders Trial in Worldwide (Inebilizumab, Placebo)

            Completed
            Has Results
            • Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
            • Birmingham, Alabama
            • +97 more
            Nov 3, 2021

            Study - Transverse Myelitis

            Completed
            • Transverse Myelitis
            • Intra spinal pressure monitoring
            • Intra spinal microdialysis monitoring
            • London, United Kingdom
              St George's, University of London
            Jan 8, 2021

            Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Ravulizumab)

            Active, not recruiting
            • Neuromyelitis Optica
            • Neuromyelitis Optica Spectrum Disorder
            • Ravulizumab
            • Birmingham, Alabama
            • +67 more
            Feb 3, 2022

            Prognostic Factors of Acute Transverse Myelitis

            Not yet recruiting
            • Transverse Myelitis
            • MRI
            • (no location specified)
            Sep 27, 2023

            Acute Demyelinating Syndrome Trial in France (Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of

            Not yet recruiting
            • Acute Demyelinating Syndrome
            • Immediate Azathioprine (1st attack)
            • +2 more
            • Besançon, France
            • +8 more
            Sep 14, 2022

            Neuromyelitis Optica Spectrum Disorder Trial (Rituximab)

            Completed
            • Neuromyelitis Optica Spectrum Disorder
            • (no location specified)
            Oct 14, 2020

            Initial Clinical Presentation of Inflammatory Optic Neuritis

            Completed
            • Optic Neuritis
            • Non interventional study
            • Angers, France
            • +7 more
            Feb 16, 2022

            Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (eculizumab)

            Completed
            Has Results
            • Neuromyelitis Optica
            • Neuromyelitis Optica Spectrum Disorder
            • eculizumab
            • Scottsdale, Arizona
            • +68 more
            Jul 25, 2022

            Neuromyelitis Optica Spectrum Disorder Trial in Isfahan (Azathioprine, Rituximab)

            Completed
            Has Results
            • Neuromyelitis Optica Spectrum Disorder
            • Isfahan, Iran, Islamic Republic of
              Kashani Hospital
            Sep 29, 2020

            Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum

            Not yet recruiting
            • Neuromyelitis Optica Spectrum Disorders
            • (no location specified)
            Sep 29, 2023

            Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

            Not yet recruiting
            • Neuromyelitis Optica
            • Efgartigimod
            • Intravenous methylprednisolone (IVMP) and Efgartigimod
            • IVMP
            • (no location specified)
            Nov 1, 2023

            Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

            Not yet recruiting
            • Neuromyelitis Optica Spectrum Disorder
            • (no location specified)
            Jun 5, 2023

            Neuromyelitis Optica Spectrum Disorders Trial in Russian Federation (divozilimab, Placebo)

            Recruiting
            • Neuromyelitis Optica Spectrum Disorders
            • divozilimab
            • Placebo
            • Barnaul, Russian Federation
            • +18 more
            Feb 17, 2023

            Optic Neuromyelitis Spectrum Disease Trial in China (BAT4406F Injection, BAT4406F Placebos)

            Recruiting
            • Optic Neuromyelitis Spectrum Disease
            • BAT4406F Injection
            • BAT4406F Placebos
            • Baotou, China
            • +44 more
            Sep 12, 2023